CDK6, cyclin dependent kinase 6, 1021

N. diseases: 266; N. variants: 27
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.050 AlteredExpression disease BEFREE MV persistence infection of a human neuroblastoma cell line (UKF-NB-MV), exhibit high miRNA-124 expression, and reduced expression of cyclin dependent kinase 6 (CDK6), a known target of miRNA-124, resulting in slower cell division but not cell death. 29073265 2017
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.050 Biomarker disease BEFREE We evaluated the effect of dual CDK4/CDK6 inhibition on neuroblastoma viability using LEE011 (Novartis Oncology), a highly specific CDK4/6 inhibitor. 24045179 2013
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.050 Biomarker disease BEFREE This suggests an involvement of G(1)-regulating genes in neuronal differentiation processes which we further evaluated using RNA interference against Cyclin D1 and its kinase partners CDK4 and CDK6 in several neuroblastoma cell lines. 18413728 2008
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.050 GeneticVariation disease BEFREE No mutations to the p16-binding site of CDK4 and CDK6 nor any mutations to the coding region of p16 itself were identified in neuroblastoma cell lines. 9935245 1999
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.050 AlteredExpression disease BEFREE A bona fide CDK6 mutation that disrupts p16INK4a binding and prevents inhibition of CDK6 protein kinase activity was identified in 1 of 17 neuroblastoma cell lines. 9635589 1998